Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Non-Small-Cell Lung 4Recurrence 2Esophageal Neoplasms 2Carcinoma, Hepatocellular 2Solid Tumors Harboring NTRK Fusion 1Pancreatic Neoplasms 1Liver Neoplasms 1Insulin-Like Growth Factor I, Resistance To 1Advanced Solid Tumor 1

Interventions

Carboplatin 19Paclitaxel 18Fluorouracil 16Cisplatin 16pembrolizumab 15Radiotherapy 14Oxaliplatin 12Irinotecan 12Capecitabine 12Cyclophosphamide 10Radiation 8Leucovorin 8Docetaxel 8fludarabine 6Taxes 6Gemcitabine 6Trastuzumab 5fludarabine phosphate 4aldesleukin 4LY6K protein, human 4Fluorodeoxyglucose F18 4Erlotinib Hydrochloride 4Bevacizumab 4spartalizumab 3Surgical Procedures, Operative 3S 1 (combination) 3Pemetrexed 3Nivolumab 3Drug Therapy 3zimberelimab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Esophageal Neoplasms × Receptor Protein-Tyrosine Kinases × Clear all
NCT00632333 2011-07-21

Combination of Chemoradiation Therapy and Epitope Peptide Vaccine Therapy in Treating Patients With Esophageal Cancer

Teikyo University

Phase 1 Unknown
9 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT00561275 2008-07-15

Safety Study of Multiple Peptide Vaccine to Esophageal Cancer

Japanese Foundation for Cancer Research

Phase 1 Completed
6 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡